PortfoliosLab logoPortfoliosLab logo
better ibb
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Diversification

Asset Allocation


IBBQ 50.00%IHE 50.00%EquityEquity

S&P 500 Index

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in better ibb, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.


Loading graphics...

The earliest data available for this chart is Jun 11, 2021, corresponding to the inception date of IBBQ

Returns By Period


1D1MYTD6M1Y3Y*5Y*10Y*
Benchmark
S&P 500 Index
0.44%-1.90%-3.41%-1.91%30.31%17.22%10.14%12.44%
Portfolio
better ibb
-0.62%-0.28%2.09%15.49%44.47%13.49%
IBBQ
Invesco Nasdaq Biotechnology ETF
-0.45%0.64%2.08%15.27%50.30%12.36%
IHE
iShares U.S. Pharmaceuticals ETF
-0.79%-1.21%2.10%15.69%38.73%14.43%10.05%7.65%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Jun 14, 2021, better ibb's average daily return is +0.03%, while the average monthly return is +0.59%. At this rate, your investment would double in approximately 9.8 years.

Historically, 61% of months were positive and 39% were negative. The best month was Nov 2025 with a return of +10.5%, while the worst month was Jan 2022 at -8.3%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 3 months.

On a daily basis, better ibb closed higher 51% of trading days. The best single day was Apr 9, 2025 with a return of +4.2%, while the worst single day was Apr 4, 2025 at -5.4%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20262.32%4.57%-4.33%-0.27%2.09%
20255.36%2.29%-4.26%-1.59%-4.31%2.48%2.86%6.60%3.41%7.26%10.51%-0.92%32.60%
20241.55%4.00%0.29%-5.82%4.11%2.46%4.79%3.72%-2.54%-2.30%0.19%-5.95%3.78%
20231.63%-5.70%0.62%2.40%-3.99%2.47%1.49%1.97%-5.06%-5.97%4.76%9.50%2.96%
2022-8.30%-3.77%5.49%-6.52%1.23%-0.09%1.64%-4.07%-2.79%7.82%4.71%-1.59%-7.31%
20210.08%1.44%2.61%-4.88%0.40%-2.14%2.99%0.27%

Benchmark Metrics

better ibb has an annualized alpha of 0.48%, beta of 0.68, and R² of 0.43 versus S&P 500 Index. Calculated based on daily prices since June 14, 2021.

  • This portfolio participated in 83.99% of S&P 500 Index downside but only 71.86% of its upside — more exposed to losses than it benefited from rallies.
  • Beta of 0.68 may look defensive, but with R² of 0.43 this portfolio is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this portfolio's risk.
  • R² of 0.43 means the benchmark explains less than half of this portfolio's behavior — treat beta with caution or consider switching to a more representative benchmark.

Alpha
0.48%
Beta
0.68
0.43
Upside Capture
71.86%
Downside Capture
83.99%

Expense Ratio

better ibb has an expense ratio of 0.21%, which is considered low. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.


Return for Risk

Risk / Return Rank

better ibb ranks 66 for risk / return — better than 66% of portfolios on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.


better ibb Risk / Return Rank: 6666
Overall Rank
better ibb Sharpe Ratio Rank: 6969
Sharpe Ratio Rank
better ibb Sortino Ratio Rank: 5353
Sortino Ratio Rank
better ibb Omega Ratio Rank: 4646
Omega Ratio Rank
better ibb Calmar Ratio Rank: 8989
Calmar Ratio Rank
better ibb Martin Ratio Rank: 7676
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics


PortfolioBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

2.26

1.84

+0.42

Sortino ratio

Return per unit of downside risk

3.07

2.97

+0.09

Omega ratio

Gain probability vs. loss probability

1.38

1.40

-0.02

Calmar ratio

Return relative to maximum drawdown

3.90

1.82

+2.07

Martin ratio

Return relative to average drawdown

11.93

7.76

+4.17


How much return does each position deliver for the risk it carries? Higher values mean better reward for the risk taken.

Risk / Return RankSharpe ratioSortino ratioOmega ratioCalmar ratioMartin ratio
IBBQ
Invesco Nasdaq Biotechnology ETF
892.273.041.384.2314.06
IHE
iShares U.S. Pharmaceuticals ETF
812.012.781.363.259.11

Sharpe Ratio

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

better ibb Sharpe ratios as of Apr 7, 2026 (values are recalculated daily):

  • 1-Year: 2.26
  • All Time: 0.36

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

Compared to the broad market, where average Sharpe ratios range from 1.63 to 2.54, this portfolio's current Sharpe ratio falls between the 25th and 75th percentiles. This indicates that its risk-adjusted performance is in line with the majority of portfolios, suggesting a balanced approach to risk and return—likely suitable for a wide range of investors.

The chart below shows the rolling Sharpe ratio of better ibb compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.


Loading graphics...

Dividends

Dividend yield

better ibb provided a 1.30% dividend yield over the last twelve months.


TTM20252024202320222021202020192018201720162015
Portfolio1.30%1.33%1.44%1.10%1.38%1.06%0.60%0.70%0.63%0.68%0.46%0.96%
IBBQ
Invesco Nasdaq Biotechnology ETF
0.87%0.90%1.14%0.81%0.76%0.63%0.00%0.00%0.00%0.00%0.00%0.00%
IHE
iShares U.S. Pharmaceuticals ETF
1.72%1.76%1.73%1.39%2.01%1.49%1.19%1.40%1.25%1.36%0.92%1.93%

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the better ibb. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the better ibb was 23.85%, occurring on Jun 16, 2022. Recovery took 519 trading sessions.

The current better ibb drawdown is 4.64%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-23.85%Sep 3, 2021198Jun 16, 2022519Jul 12, 2024717
-18.91%Sep 3, 2024150Apr 8, 2025107Sep 11, 2025257
-8.28%Feb 25, 202623Mar 27, 2026
-5.44%Jul 29, 20248Aug 7, 20248Aug 19, 202416
-3.91%Nov 28, 20258Dec 9, 20259Dec 22, 202517

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Diversification

Diversification Metrics


Number of Effective Assets

The portfolio contains 2 assets, with an effective number of assets of 2.00, reflecting the diversification based on asset allocation. This number of effective assets suggests a highly concentrated portfolio, where a few assets dominate the allocation, potentially increasing the portfolio's risk due to lack of diversification.

Asset Correlations Table

The table below displays the correlation coefficients between the individual components of the portfolio, the entire portfolio, and the chosen benchmark.

BenchmarkIHEIBBQPortfolio
Benchmark1.000.530.590.60
IHE0.531.000.700.89
IBBQ0.590.701.000.94
Portfolio0.600.890.941.00
The correlation results are calculated based on daily price changes starting from Jun 14, 2021